Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients

George T. H. Ellison; Jay S. Kaufman; Rosemary F. Head; Paul A. Martin; Jonathan D. Kahn

doi:10.1111/j.1748-720x.2008.290.x

Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients

George T. H. Ellison, Jay S. Kaufman, Rosemary F. Head, Paul A. Martin, Jonathan D. Kahn

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	449-457
Journal	The Journal of Law Medicine & Ethics
Volume	36
Issue number	3
DOIs	https://doi.org/10.1111/j.1748-720x.2008.290.x
Publication status	Published - Sept 2008
Externally published	Yes

Keywords

Social work and social policy and administration

Access to Document

10.1111/j.1748-720x.2008.290.x

http://dx.doi.org/10.1111/j.1748-720x.2008.290.x

Cite this

@article{63fefd0e068c4500ab790f38b91d94e6,

title = "Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients",

keywords = "Social work and social policy and administration",

author = "Ellison, \{George T. H.\} and Kaufman, \{Jay S.\} and Head, \{Rosemary F.\} and Martin, \{Paul A.\} and Kahn, \{Jonathan D.\}",

year = "2008",

month = sep,

doi = "10.1111/j.1748-720x.2008.290.x",

language = "English",

volume = "36",

pages = "449--457",

journal = "The Journal of Law Medicine \& Ethics",

issn = "1073-1105",

number = "3",

}

Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients. / Ellison, George T. H.; Kaufman, Jay S.; Head, Rosemary F. et al.
In: The Journal of Law Medicine & Ethics, Vol. 36, No. 3, 09.2008, p. 449-457.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients

AU - Ellison, George T. H.

AU - Kaufman, Jay S.

AU - Head, Rosemary F.

AU - Martin, Paul A.

AU - Kahn, Jonathan D.

PY - 2008/9

Y1 - 2008/9

KW - Social work and social policy and administration

U2 - 10.1111/j.1748-720x.2008.290.x

DO - 10.1111/j.1748-720x.2008.290.x

M3 - Article

SN - 1073-1105

VL - 36

SP - 449

EP - 457

JO - The Journal of Law Medicine & Ethics

JF - The Journal of Law Medicine & Ethics

IS - 3

ER -